Blueprint Medicines Corp (BPMC)
108.67
+2.42
(+2.28%)
USD |
NASDAQ |
May 07, 16:00
108.62
-0.05
(-0.05%)
After-Hours: 20:00
Blueprint Medicines Total Long Term Debt (Quarterly): 239.38M for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 239.38M |
December 31, 2023 | 238.81M |
September 30, 2023 | 238.38M |
June 30, 2023 | 140.00M |
March 31, 2023 | 139.51M |
December 31, 2022 | 139.08M |
September 30, 2022 | 138.35M |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
Date | Value |
---|---|
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.277M |
June 30, 2018 | 0.692M |
March 31, 2018 | 1.106M |
December 31, 2017 | 1.518M |
September 30, 2017 | 2.095M |
June 30, 2017 | 2.671M |
March 31, 2017 | 3.246M |
December 31, 2016 | 4.069M |
September 30, 2016 | 4.887M |
June 30, 2016 | 5.705M |
March 31, 2016 | 6.518M |
December 31, 2015 | 7.338M |
September 30, 2015 | 7.871M |
June 30, 2015 | 8.262M |
March 31, 2015 | 8.652M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
239.38M
Maximum
Mar 2024
63.68M
Average
--
Median
Jun 2019
Total Long Term Debt (Quarterly) Benchmarks
Apellis Pharmaceuticals Inc | 93.03M |
Alnylam Pharmaceuticals Inc | 1.022B |
Ionis Pharmaceuticals Inc | 1.283B |
Madrigal Pharmaceuticals Inc | -- |
Sarepta Therapeutics Inc | 1.239B |